Skip to main content
Livermore
Livermore
ZHEN

Valley Brook Capital Group

SEC CIK
0001851418
Latest filing
Jul 27, 2026

ABT holding history

Abbott Laboratories in every 13F filed by Valley Brook Capital Group, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ABT overviewAll 13F holders of ABTFull Q2 2026 holdings

Shares (Q2 2026)
9,447
Value
$857.2K
% of portfolio
0.5%
Quarters held
22
Since Q1 2021
Holdings of ABT by Valley Brook Capital Group, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20269,447$857.2K0.5%−875−8.5%ReducedHolders
Q1 202610,322$1.06M0.7%00.0%UnchangedHolders
Q4 202510,322$1.29M0.9%−240−2.3%ReducedHolders
Q3 202510,562$1.41M1.0%−28−0.3%ReducedHolders
Q2 202510,590$1.44M1.1%00.0%UnchangedHolders
Q1 202510,590$1.40M1.1%−106−1.0%ReducedHolders
Q4 202410,696$1.21M0.9%−181−1.7%ReducedHolders
Q3 202410,877$1.24M0.9%+127+1.2%AddedHolders
Q2 202410,750$1.12M0.9%−25−0.2%ReducedHolders
Q1 202410,775$1.22M1.0%−1,787−14.2%ReducedHolders
Q4 202312,562$1.38M1.2%−550−4.2%ReducedHolders
Q3 202313,112$1.27M1.3%+50+0.4%AddedHolders
Q2 202313,062$1.42M1.3%+100+0.8%AddedHolders
Q1 202312,962$1.31M1.2%+150+1.2%AddedHolders
Q4 202212,812$1.41M1.3%−300−2.3%ReducedHolders
Q3 202213,112$1.27M1.4%00.0%UnchangedHolders
Q2 202213,112$1.42M1.5%+100+0.8%AddedHolders
Q1 202213,012$1.54M1.3%+525+4.2%AddedHolders
Q4 202112,487$1.76M1.5%00.0%UnchangedHolders
Q3 202112,487$1.48M1.5%−250−2.0%ReducedHolders
Q2 202112,737$1.48M1.4%+156+1.2%AddedHolders
Q1 202112,581$1.51M1.4%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.